Evidence map›Paper›PMID 39478586›Full record

ArticleCritical care (London, England)2024

Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock.

Klaus Stahl, Georg F Lehner, Pedro David Wendel-Garcia, Benjamin Seeliger, Thorben Pape, Bernhard M W Schmidt, Heiko Schenk, Julius Schmitt, Andrea Sauer, Lennart Wild and 5 more

Abstract read
In one paragraph

Article in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A few words of caution on blood purification in sepsis.Critical care (London, England) · 2025
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Klaus StahlDepartment of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Georg F LehnerDivision of Intensive Care and Emergency Medicine, Medical University Innsbruck, Innsbruck, Austria.
Pedro David Wendel-GarciaInstitute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.
Benjamin SeeligerDepartment of Respiratory Medicine and German Centre of Lung Research (DZL), Hannover Medical School, Hannover, Germany.
Thorben PapeDepartment of Respiratory Medicine and German Centre of Lung Research (DZL), Hannover Medical School, Hannover, Germany.
Bernhard M W SchmidtDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Heiko SchenkDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Julius SchmittDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Andrea SauerDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Lennart WildDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Konrad PeukertDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Christian PutensenDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Christian BodeDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
Michael Joannidis *Division of Intensive Care and Emergency Medicine, Medical University Innsbruck, Innsbruck, Austria.
Sascha David *Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland. sascha.david@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoagulopathy is part of the pathological host response to infection in sepsis. Higher plasma concentrations of both tissue factor (TF) and tissue factor pathway inhibitor (TFPI) are associated with occurrence of disseminated intravascular coagulation (DIC), multi-organ dysfunction and increased mortality in patients with sepsis. Currently no treatment approaches specifically targeting this axis are available. We hypothesize that therapeutic plasma exchange (TPE) might limit this coagulopathy by restoring the balance of plasma proteins.

methodsThis was a pooled post-hoc biobank analysis including 51 patients with early (shock onset < 24 h) and severe (norepinephrine dose > 0.4 μg/kg/min) septic shock, who were either receiving standard of care treatment (SOC, n = 14) or SOC + one single TPE (n = 37). Plasma concentrations of TF and TFPI were measured both at- and 6 h after study inclusion. The effect of TPE on concentrations of TF and TFPI was investigated and compared to SOC patients. Further, baseline TF and TFPI concentrations were used to modulate and predict clinical response to adjunctive TPE, indicated by longitudinal reduction of lactate concentrations over the first 24 h following study inclusion.

resultsTPE led to a significant reduction in circulating concentrations of both TF and TFPI while no difference was observed in the SOC group. Relative change of TF within 6 h was + 14 (-0.8 to + 30.4) % (p = 0.089) in the SOC and -18.3 (-32.6 to -2.2) % (p < 0.001) in the TPE group (between group p < 0.001). Similarly, relative change of TFPI was + 14.4 (-2.3 to + 30.9) % (p = 0.076) in the SOC and -20 (-32.8 to -7.9) % (p < 0.001) in the TPE group (between group p = 0.022). The ratio of TF to TFPI remained unchanged in both SOC and TPE groups. SOC patients exhibited an increase in lactate over the initial 24 h when TF and TFPI concentrations were higher at baseline. In contrast, patients undergoing TPE experienced a sustained longitudinal reduction of lactate concentrations across all levels of baseline TF and TFPI elevations. In a multivariate mixed-effects model, higher baseline TF (p = 0.003) and TFPI (p = 0.053) levels led to greater longitudinal lactate concentration reduction effects in the TPE group.

conclusionsAdjunctive TPE in septic shock is associated with a significant removal of both TF and TFPI, which may contribute to the early hemodynamic improvement observed in septic shock patients receiving TPE. Higher baseline TF (and TFPI) plasma concentrations were identified as a putative predictor of treatment response that could be useful for predictive enrichment strategies in future clinical trials.

Indexed as

LipoproteinsPlasma ExchangeShock, SepticThromboplastinAgedFemaleHumansMaleMiddle Agedlipoprotein-associated coagulation inhibitorLipoproteinsThromboplastinApheresisCoagulationExtracorporeal treatmentPlasmapheresisPrecision medicineSepsisTissue factorTissue factor pathway inhibitor

Identifiers

PMID39478586
PMCPMC11526504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.